Generate Biomedicines, Inc. - GENB
Sector:
Healthcare
· Industry:
Biotechnology
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$1.688B
QoQ value delta ($000)
+$534.2M
(+46.3%)
Implied price effect (QoQ)
+35.31%
Shares
Total shares
100,045,749
QoQ shares delta
+7,520,782
(+8.13%)
Total shares held by funds (by quarter)
Market chart (GENB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Flagship Pioneering, LLC | 1,057,295 | 62,673,117 | 68.66% |
| FMR LLC | 88,088 | 5,221,599 | 0.0% |
| Capital World Investors | 71,117 | 4,215,632 | 0.01% |
| BRAIDWELL LP | 55,398 | 3,283,844 | 2.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 36,383 | 2,156,627 | 0.0% |
| NORGES BANK | 35,336 | 2,094,616 | 0.0% |
| ARCH Venture Management, LLC | 32,802 | 1,944,426 | 2.98% |
| HARBOURVEST PARTNERS LLC | 29,053 | 1,722,210 | 17.09% |
| BlackRock, Inc. | 28,003 | 1,659,966 | 0.0% |
| BAKER BROS. ADVISORS LP | 24,016 | 1,423,602 | 0.12% |
| JPMORGAN CHASE & CO | 23,837 | 1,409,649 | 0.0% |
| Deep Track Capital, LP | 22,501 | 1,333,815 | 0.33% |
| ARK Investment Management LLC | 21,671 | 1,284,617 | 0.14% |
| VANGUARD CAPITAL MANAGEMENT LLC | 19,109 | 1,132,750 | 0.0% |
| HARVARD MANAGEMENT CO INC | 18,744 | 1,111,100 | 0.44% |
| NVIDIA CORP | 14,058 | 833,325 | 0.02% |
| Davern Capital Partners, LP | 13,912 | 824,679 | 2.37% |
| Siren, L.L.C. | 12,418 | 736,104 | 0.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 12,402 | 735,003 | 0.0% |
| STATE STREET CORP | 8,883 | 526,565 | 0.0% |
| Affinity Asset Advisors, LLC | 6,748 | 400,000 | 0.3% |
| MORGAN STANLEY | 6,376 | 377,994 | 0.0% |
| UBS Group AG | 5,504 | 326,273 | 0.0% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,133 | 245,000 | 0.54% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3,789 | 224,602 | 0.0% |